COVID-19 Clinical Management: The Experts' Perspective

In this first presentation of a four-part series, a panel of Baylor College of Medicine-affiliated experts share current evidence and trends in the clinical management of COVID-19. Dr. Laila Woc-Colburn, M.D. discusses the typical clinical presentation of the disease. Dr. Sergio Trevino Castillo, M.D. discusses intensive care management of COVID-19 pneumonia. Dr. Hana El Sahly, M.D. discusses antiviral treatment approaches, including recent data on remdesivir. Dr. Ivan Rosas, M.D. defers his presentation until the second presentation in the series.

Target Audience

Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Summarize the evidence on the role of antivirals and immunomodulators in COVID-19 management.
  • Describe the clinical presentation of mild-to-moderate COVID-19.
  • Illustrate atypical presentations of COVID-19.
  • Describe the clinical symptoms of COVID-19 as associated with pathophysiology.
  • Explain the individualized approach that COVID-19 patients require to be managed in the ICU.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
Course opens: 
03/31/2020
Course expires: 
04/30/2022
Rating: 
0

Hana El Sahly, M.D., Contributor
Associate Professor
Department of Medicine, Section of Virology and Microbiology
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Stephen B. Greenberg, M.D., Planning Committee Member
Distinguished Service Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Richard J. Hamill, M.D., Planning Committee Member
Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Erica Lescinskas, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Ivan Rosas, M.D., Contributor
Professor and Section Chief
Department of Medicine, Section of Pulmonary, Critical Care and Sleep Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Research support: Genentech/Roche; Consultancy: Boehringer, Bristol Meyers Squibb, Genentech/Roche

Zaven Sargsyan, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose. 

Chirayu Shah, M.D., M.Ed., Planning Committee Member
Associate Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Stephanie V. Sherman, M.D., Planning Committee Member
Assistant Professor
Department of Medicine
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Sergio Trevino Castillo, Contributor
Assistant Professor
Department of Medicine, Section of Pulmonology
Baylor College of Medicine
Houston, Texas
Disclosure: Nothing to disclose.

Laila Woc-Colburn, M.D., DTM&H, Contributor
Associate Professor
Department of Medicine, Section of Infectious Diseases
Baylor College of Medicine
Houston, Texas
Disclosure: Honorarium recipient: Elsevier, McGraw-Hill.

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
Please login or register to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox, and Google Chrome.